The paradoxical roles of miR-4295 in human cancer: Implications in pathogenesis and personalized medicine

Yin Li; Yihan Zhang; Yuhao Zou; Shiwei Duan

doi:10.1016/j.gendis.2020.09.007

您当前的位置：

首页 >

文章列表页 >

The paradoxical roles of miR-4295 in human cancer: Implications in pathogenesis and personalized medicine

更新时间：2022-06-24

- The paradoxical roles of miR-4295 in human cancer: Implications in pathogenesis and personalized medicine
- Genes & Diseases Vol. 9, Issue 3, (2022)
- 作者机构：
  
  Medical Genetics Center, Ningbo University School of Medicine,Zhejiang,Ningbo,PR China,315211
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2020.09.007
  CLC：
- Published：2022，
  
  Published Online：1 May 2022，
扫描看全文
Yin Li, Yihan Zhang, Yuhao Zou, et al. The paradoxical roles of miR-4295 in human cancer: Implications in pathogenesis and personalized medicine. [J]. Genes & Diseases 9(3).(2022)
DOI：

Yin Li, Yihan Zhang, Yuhao Zou, et al. The paradoxical roles of miR-4295 in human cancer: Implications in pathogenesis and personalized medicine. [J]. Genes & Diseases 9(3).(2022) DOI： 10.1016/j.gendis.2020.09.007.

摘要

Abstract

MiR-4295

located on chromosome 10q25.2

is a unique miRNA with a wide range of biological functions. miR-4295 is widely expressed

in vivo

participating in the biological processes of multiple cancers. Although miR-4295 is dysregulated in various cancers

it has also been found to have the function of inhibiting cancer. At the same time

the expression of miR-4295 is related to prognosis and can be affected by numerous factors connecting to the therapeutic effects of various drugs. This article is to better summarize the role of miR-4295 in cancer and review the potential diagnostic

prognostic

and therapeutic value of miR-4295

which may provide insight into subsequent research.

关键词

Keywords

CancerCancer cellsmiR-4295Molecular functionPrognosisTumor suppressor

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

MicroRNA-9 as a paradoxical but critical regulator of cancer metastasis: Implications in personalized medicine

The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis

Tumor suppressor p53 cross-talks with TRIM family proteins

miR-106b as an emerging therapeutic target in cancer

De novo nucleotide biosynthetic pathway and cancer

Related Author

Yichen Liu

Qiong Zhao

Tao Xi

Lufeng Zheng

Xiaoman Li

Mohammad Reza Zinatizadeh

Seyed Rouhollah Miri

Peyman Kheirandish Zarandi

Related Institution

Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine

School of Life Science and Technology, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 639 Longmian Road

Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran

Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Science, Tehran

Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran

⁰